Status:
NOT_YET_RECRUITING
Precision Medicine Study on Cardiovascular Disease (PRECISE)
Lead Sponsor:
China National Center for Cardiovascular Diseases
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
Brief Summary
Cardiovascular diseases are the leading cause of death in China and have become a financial burden on society under the traditional medical model. A new and sustainable medical model is needed to solv...
Detailed Description
In this study, patients with monogenic cardiovascular disease are recruited prospectively after informed consent was given. The investigator will collect the baseline clinical characteristics of the p...
Eligibility Criteria
Inclusion
- Patients with monogenic cardiovascular diagnosed according current practice guideline.
Exclusion
- Patients who refuse to sign the informed consent or decline follow-up.
Key Trial Info
Start Date :
March 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 10 2030
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT04434911
Start Date
March 10 2021
End Date
October 10 2030
Last Update
March 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai hospital
Beijing, Beijing Municipality, China, 100037